COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,786 Articles (22,946 medRxiv, 8,840 bioRxiv)

Most recent first Previous |  Page 1344: Articles 13431-13440  | Next

Disability-adjusted life years (DALYs) due to the direct health impact of COVID-19 in India, 2020
Singh, B. B., Devleesschauwer, B., Khatkar, M. S., Lowerison, M., Singh, B., Dhand, N. K., Barkema, H. W.
10.1101/2021.08.20.21262326 — Posted: 2021-08-22
Large-scale study of antibody titer decay following BNT162b2 mRNA vaccine or SARS-CoV-2 infection
Israel, A., Shenhar, Y., Green, I., Merzon, E., Golan-Cohen, A., Schäffer, A. A., Ruppin, E., Vinker, S., Magen, E.
10.1101/2021.08.19.21262111 — Posted: 2021-08-22 Discussion: Onsite
Intention to receive a COVID-19 vaccine by HIV status among a population-based sample of women and gender diverse individuals in British Columbia, Canada
Kaida, A., Brotto, L. A., Murray, M. C. M., Cote, H. C. F., Albert, A. Y., Nicholson, V., Gormley, R., Gordon, S., Booth, A., Smith, L. W., Baaske, A., Galea, L. A. M., Sadarangani, M., Ogilvie, G. S.
10.1101/2021.08.19.21262249 — Posted: 2021-08-22
Virtual Delivery of Simulation Education to Undergraduate Medical Students During the COVID-19 Pandemic
Wu, K., Chan, A., Pandey, A., Panchal, P., Khalid, M., Bala, S., Shah, S., Miller, M. C.
10.1101/2021.08.20.21262347 — Posted: 2021-08-22
A prospective study of the protective effect of SARS-CoV-2-specific antibodies and T cells in Moscow residents
Molodtsov, I., Kegeles, E., Mitin, A., Mityaeva, O., Musatova, O., Panova, A., Pashenkov, M., Peshkova, I., Almaqdad, A., Asaad, W., Budikhina, A., Deryabin, A., Dolzhikova, I., Filimonova, I., Gracheva, A., Ivanova, O., Kizilova, A., Komogorova, V., Komova, A., Kompantseva, N., Lagutkin, D., Lomakin, Y., Maleeva, A., Maryukhnich, E., Mohammad, A., Murugin, V., Murugina, N., Navoikova, A., Nikonova, M., Ovchinnikova, L., Pinegina, N., Potashnikova, D., Romanova, E., Saidova, A., Sakr, N., Samoilova, A., Serdyuk, Y., Shakirova, N., Sharova, N., Sheetikov, S., Shemetova, A., Shevkova, L., Shpektor, A., Trufanova, A., Tvorogova, A., Ukrainskaya, V., Vinokurov, A., Vorobyeva, D., Zornikova, K., Efimov, G., Khaitov, M., Kofiadi, I., Komissarov, A., Logunov, D., Naigovzina, N., Rubtsov, Y., Vasilyeva, I., Volchkov, P., Vasilieva, E.
10.1101/2021.08.19.21262278 — Posted: 2021-08-22 Discussion: Onsite
Reduced serum neutralization capacity against SARS-CoV-2 variants in a multiplex ACE2 RBD competition assay
Junker, D., Dulovic, A., Becker, M., Wagner, T. R., Kaiser, P. D., Traenkle, B., Rothbauer, U., Kienzle, K., Bunk, S., Strümper, C., Häberle, H., Schmauder, K., Malek, N., Althaus, K., Koeppen, M., Bitzer, M., Göpel, S., Schneiderhan-Marra, N.
10.1101/2021.08.20.21262328 — Posted: 2021-08-22
Seroresponse to SARS-CoV-2 vaccines among maintenance dialysis patients
Hsu, C. M., Weiner, D. E., Aweh, G. N., Manley, H. J., Ladik, V., Frament, J., Miskulin, D., Agyropoulos, C., Abreo, K., Chin, A., Gladish, R., Salman, L., Johnson, D., Lacson, E. K.
10.1101/2021.08.19.21262292 — Posted: 2021-08-22
Inhaled nitric oxide use in COVID19-induced hypoxemic respiratory failure.
Giri, A. R., Yarrarapu, S. N. S., Kaur, N., Hochwald, A. P., Crook, J., Helgeson, S., Harrison, M. F., Patel, N., Guru, P. K., Lowman, P., Moreno-Franco, P., Lee, A., Sanghavi, D. K.
10.1101/2021.08.19.21262314 — Posted: 2021-08-21
Can a vaccine-led approach end the NSW outbreak in 100 days, or at least substantially reduce morbidity and mortality?
Bablani, L., Wilson, T., Andrabi, H., Sundararajan, V., Ait Oukarim, D., Abraham, P., Thompson, J., Blakely, T.
10.1101/2021.08.18.21262252 — Posted: 2021-08-21
Effect of familiarity with COVID-19 infection--history of infection or close contact--on outing behaviors when a state of emergency is declared
MORI, T., Nagata, T., Ikegami, K., Hino, A., Tateishi, S., Tsuji, M., Matsuda, S., Fujino, Y., Mori, K.
10.1101/2021.08.20.21262364 — Posted: 2021-08-21

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).